alexa Postoperative Atrial Fibrillation and N-Acetyl Cysteine | OMICS International
ISSN: 2155-9880
Journal of Clinical & Experimental Cardiology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Postoperative Atrial Fibrillation and N-Acetyl Cysteine

Mehmet Ozaydin*
Professor of Cardiology, Department of Cardiology, Suleyman Demirel University, Isparta, Turkey
Corresponding Author : Mehmet Ozaydin
Professor of Cardiology
Department of Cardiology
Suleyman Demirel University
Kurtulus Mah, 122. Cad, No: 126/15, 32040, Isparta, Turkey
Tel: (90)5324139528
E-mail: [email protected]
Received: September 06, 2012; Accepted: September 06, 2012; Published: September 08, 2012
Citation: Ozaydin M (2012) Postoperative Atrial Fibrillation and N-Acetyl Cysteine. J Clin Exp Cardiolog 3:e112 doi:10.4172/2155-9880.1000e112
Copyright: © 2012 Ozaydin M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Clinical & Experimental Cardiology

Keywords
N-acetyl cysteine; Postoperative atrial fibrillation
Postoperative Atrial Fibrillation
Postoperative atrial fibrillation (POAF) is the most common complication of cardiac surgery. It is associated with severe complications including stroke, hypotension and mortality and increased duration of hospitalization and cots of the procedure [1,2].
Recent investigations have suggested that cardiopulmonary bypass surgery may be associated with oxidative stress and inflammation, processes that are interrelated and have been implicated in the atrial remodeling and therefore the development and perpetuation of atrial fibrillation (AF) [3-15].
N-Acetyl Cysteine and Postoperative Atrial Fibrillation
N-acetyl cysteine (NAC) is a mucolytic agent and it has been used as an antidote for aceteminophen intoxication [16]. It has anti-oxidant and anti-inflammatory properties. It is a glutathione precursor, may scavenge reactive oxygen species and reduce oxidative damage [17,18]. Therefore, it seems that it is a promising agent that can be used for the prevention of POAF. In this review, we focus on the studies searching the association between POAF and NAC.
N-acetyl cysteine has been shown to reduce oxidative and inflammatory response [19-21], ischemia/ reperfusion injury [22], and reperfusion arrhythmias [23].
In 20 patients undergoing by-pass surgery, Eren et al. [24] compared the patients receiving NAC to those receiving salt solution and found that the incidence of POAF was lower in the salt group (10%) than the NAC group (20%). Orhan et al. [22] also compared the NAC group with control group in a total of 20 patients and no difference was detected with respect to POAF rate between the groups. Haase et al. [25] also showed that the NAC group and the placebo group developed similar rate of POAF (p=0.42) in a phase II study performed in 60 cardiac surgery patients at high risk of postoperative heart failure. Although statistically insignificant, POAF rate was found to be lower in the NAC group as compared with the placebo group (p=0.21) in the study of Wijeysundera, [26] who randomized 177 cardiac surgery patients with moderate renal insufficiency to NAC or placebo. On the contrary, El-Hamamsy et al. [27] indicate no beneficial effects of NAC on any end-points including POAF in a randomized study. POAF was not primary end-point in any of the above studies.
In only our randomized [28] study POAF was primary end-point. We included 115 patients undergoing by-pass and/or valve surgery and compared the effects of NAC or saline as placebo and found that POAF incidence was significantly lower in patients receiving NAC as compared to those receiving placebo. In an observational study including 590 patients, we obtained the similar positive results in similar patient group [29]. These findings were supported by two recent meta-analyses [30,31]. In the meta-analysis of Baker et al. [30] POAF was end-point in 6 studies and its risk decreased significantly (36%) with NAC. In the meta-analysis by Gu et al. [31] including 8 studies with 578 patients, it was shown that POAF was significantly reduced by NAC compared to controls. However, it was recognized that a large randomized trial with POAF as primary endpoint was needed. On the other hand, another meta-analysis [32] including 1407 patients was unable to indicate any benefical effects of NAC on POAF (p=0.19).
NAC has sulfydryl group and therefore it may decrease ischemiareperfusion injury and may have vasodilator actions [22]. Also, it may increase Ito and ICa,L current, and may affect atrial remodeling [33,34].
Conclusions
Available data to date indicate that, although promising results have been obtained, there is no homogeneity in all the studies. Therefore, it is early to recommend NAC routinely for the prevention of POAF. Large randomized trials with POAF as primary endpoint comparing different doses and durations of treatment are needed.
References


































Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11717
  • [From(publication date):
    October-2012 - Jun 25, 2018]
  • Breakdown by view type
  • HTML page views : 7937
  • PDF downloads : 3780
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7